<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">jpts-2014-108</article-id><article-id pub-id-type="doi">10.1589/jpts.26.1733</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Effects of Tai Chi on the Renal and Cardiac Functions of Patients with
Chronic Kidney and Cardiovascular Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Zhi-Min</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wen</surname><given-names>Hai-Ping</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Fu-Rong</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yao</surname><given-names>Chun-Xia</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><aff id="aff1"><label>1)</label> Medical College of Hebei University of Engineering, China</aff><aff id="aff2"><label>2)</label> HanDan Central Hospital, China</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Chun-Xia Yao, Medical College of Hebei University of Engineering: Cong
Tai Road 83, Handan 056002, Hebei Province, China. (E-mail: <email xlink:href="yaoyao20050208@163.com">yaoyao20050208@163.com</email>)</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2014</year></pub-date><volume>26</volume><issue>11</issue><fpage>1733</fpage><lpage>1736</lpage><history><date date-type="received"><day>26</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>16</day><month>5</month><year>2014</year></date></history><permissions><copyright-statement>2014&#x000a9;by the Society of Physical Therapy Science</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] To assess the effects of Tai Chi on the renal and cardiac functions of patients
with chronic kidney disease (CKD) and cardiovascular disease (CVD). [Subjects and Methods]
Twenty-one patients with CKD and CVD were randomly divided into control and exercise
groups. The exercise group performed Tai Chi training for 30 minutes three to five times a
week for 12 weeks, while the control group did not. All patients&#x02019; renal and cardiac
functions and blood lipid parameters were measured at baseline and after 12 weeks.
[Results] The 12 weeks Tai Chi intervention improved the estimated glomerular filtration
rate (eGFR), left ventricular ejection fraction (LVEF), and the high density lipoprotein
(HDL) level, and decreased the serum creatintine (Scr) level, heart rate (HR), systolic
blood pressure (SBP), diastolic blood pressure (DBP), and the total cholesterol (CH),
triglyceride (TG) and low density lipoprotein (LDL) levels. The change in eGFR correlated
negatively with the changes in CH, TG and LDL, and positively with the change in HDL. In
addition, the change in SBP correlated positively with the changes in CH, TG and LDL, and
negatively with the change in HDL. [Conclusion] Tai Chi training might improve the renal
and cardiac functions of CKD and CVD patients via improved regulation of lipid
metabolism.</p></abstract><kwd-group><title>Key words</title><kwd>Tai Chi</kwd><kwd>Renal function</kwd><kwd>Lipid metabolism</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Chronic kidney disease (CKD), also known as chronic renal disease, is a gradual loss of
kidney function over time. Many studies have demonstrated that CKD patients face increased
risk of cardiovascular disease (CVD), which has a significant impact upon patient
mortality<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>. Therefore, the prevention
and treatment of CVD has become the key to the management of patients with CKD.</p><p>Patients with a range of CKD and CVD symptoms suffered from poor physical performance.
Sietsema et al. found that reduced exercise capacity was associated with poorer survival
among ambulatory patients with end-stage renal diseases<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>. Stack et al. also reported that physical exercise reduced by about
30% the risk of death of patients receiving hemodialysis<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>. Moreover, some studies have shown that appropriate physical
activity such as aerobic exercise can improve the renal and cardiac functions of individuals
with CKD<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref><sup>)</sup>. Based on these
observations, CKD patients are encouraged to exercise, particularly aerobic and resistance
exercises<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>. Examples of aerobic exercise are brisk walking, jogging, swimming,
cycling, climbing stairs, and Tai Chi and et al. Tai Chi is a traditional Chinese exercise
which has moderate intensity, and it has been found to benefit for healthy persons and
patients with Parkinson&#x02019;s disease, heart failure, myocardial infarction, and hypertension,
to improving the quality of life and cardiovascular function<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref><sup>)</sup>.</p><p>As a type of exercise for health and fitness, Tai Chi is widely practiced in many
countries. However, the clinical effects and molecular mechanisms of Tai Chi in CKD patients
have not been well studied. Therefore, it is important to further evaluate the effects of
Tai Chi on CKD patients. In this study, we performed a clinical study and investigated
whether Tai Chi can improve the renal and cardiac functions of patients with CKD and
CVD.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>This study was a 12 week randomized controlled trial which included 21 CKD patients with
CVD. The patients were randomly divided into exercise (n=11) and control (n=10) groups. The
exercise group performed Tai Chi training for 30 minutes three to five times a week for 12
weeks, while the control group did not. Both groups received routine medical treatment for
CVD and CKD. We tested all patients&#x02019; renal and cardiac functions and blood lipid parameters
at baseline and after 12 weeks.</p><p>The study protocol was carried out in accordance with the Declaration of Helsinki and was
approved by the Medical College&#x02019;s Ethics Committee of Hebei University of Engineering.
Written informed consent was obtained from each patient.</p><p>A total of 21 patients with CKD and CVD (male/female: 14/7; mean age: 69.4&#x000b1;7.7&#x02005;years; left
ventricular ejection fraction 56.4&#x000b1;12.6%) were recruited from Han Dan Central Hospital in
China. The baseline characteristics of the study population are given in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Baseline characteristics</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Characteristic</th><th valign="middle" align="center" rowspan="1" colspan="1">Control<break/>(n=10)</th><th valign="middle" align="center" rowspan="1" colspan="1">Tai Chi<break/>(n=11)</th><th valign="middle" align="center" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">68.4&#x000b1;8.7</td><td align="center" rowspan="1" colspan="1">69.5&#x000b1;6.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Left ventricular ejection fraction (%)</td><td align="center" rowspan="1" colspan="1">56.3&#x000b1;13.9</td><td align="center" rowspan="1" colspan="1">56.5&#x000b1;12.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Beta-blocker</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Angiotensin II antagonist</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Angiotensin-coverting enzyme inhibitor</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ca-antagonist</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nitrate</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidemia</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap>. Exclusion criteria were: left ventricular ejection fraction &#x02264;30%;
proteinuria&#x02265;1&#x02005;g/day; nephritic syndrome; rapidly progressive golmerulonephritis; history of
low pulmonary function; unable to exercise.</p><p>The Tai Chi intervention consisted of 10 minutes of warm-up exercises, 30 minutes of Tai
Chi practice and 5 minutes of cool-down exercises. Ten core movements were chosen from
classical Yang-style Tai Chi and taught by 1 or 2 experienced instructors. After four weeks
of supervised training, patients were encouraged to continue their exercise program
unsupervised at home at least three to five times per week for eight weeks. Home practice
was tracked via self-report logs.</p><p>Blood urea nitrogen (BUN), serum creatintine (Scr), total cholesterol (CH), triglyceride
(TG), low density lipoprotein (LDL) and high density lipoprotein (HDL) were evaluated using
standard laboratory methods on a Hitachi 912 Chemistry Analyzer (Roche Diagnostics,
Germany). eGFR was estimated by using the following equation of the Modification of Diet in
Renal Disease Study for Chinese: eGFR (ml&#x000b7;min<sup>&#x02212;1</sup>&#x000b7;1.73 m<sup>&#x02212;2</sup>) =186 &#x000d7;
[Scr]<sup>&#x02212;1.154</sup> &#x000d7; [age]<sup>&#x02212;0.203</sup> &#x000d7; [0.742 (if female)] &#x000d7; [1.233 (Chinese
coefficient)]<xref rid="r14" ref-type="bibr">14</xref><sup>)</sup>.</p><p>BP was measured by an expert physician using a stethoscope and a sphygmomanometer via the
auscultatory method while the patients were relaxed. The first and last Korotkoff sounds
were recorded as systolic and diastolic blood pressure (SBP and DBP), respectively.</p><p>The echocardiographic examination was performed by two experienced specialists using a GE
Vivid 7 or Vivid 9 ultrasound systems. The measurements included left ventricular diastolic
diameter (LVDD), left ventricular systolic diameter (LVSD) and left ventricular ejection
fraction (LVEF).</p><p>All data are expressed as mean &#x000b1; SEM. The two-way analysis of variance was performed to
detect statistical differences. The Mann-Whitney U test and the Wilcoxon test were
respectively performed to investigate the differences between groups, and between baseline
and after 12 weeks intervention. Association of eGFR and blood lipid parameters was
evaluated using Pearson&#x02019;s correlation coefficient. All statistical analyses were carried out
using a commercially available statistical package SPSS version 12.0. Values of p&#x0003c;0.05
were considered statistically significant.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>No differences were observed between the control and the exercise groups with respect to
renal function, blood lipid parameters, BP and cardiac function at baseline (<xref rid="tbl_001" ref-type="table">Table 1</xref>). All of the 21 patients fully completed the
study. Medical treatment was maintained constantly, and no clinical events were recorded
during the study period.</p><p>As shown in <xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Comparison of renal function between baseline and 12 weeks</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="left" colspan="1"/><th colspan="2" align="center" rowspan="1">Control group</th><th colspan="2" align="center" rowspan="1">Exercise group</th></tr><tr><th colspan="2" align="center" rowspan="1"><hr/></th><th colspan="2" align="center" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">12 weeks</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">12 weeks</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BUN (mg/dl)</td><td align="center" rowspan="1" colspan="1">25.1&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">28.0&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">25.6&#x000b1;2.4</td><td align="center" rowspan="1" colspan="1">24.2&#x000b1;1.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Scr (mg/dl)</td><td align="center" rowspan="1" colspan="1">1.3&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">1.5&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">1.3&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">1.1&#x000b1;0.2<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">eGFR(ml&#x02022;min<sup>-1</sup>&#x02022;1.73m<sup>-2</sup>)</td><td align="center" rowspan="1" colspan="1">45&#x000b1;8.5</td><td align="center" rowspan="1" colspan="1">43&#x000b1;7.8</td><td align="center" rowspan="1" colspan="1">45&#x000b1;7.6</td><td align="center" rowspan="1" colspan="1">51&#x000b1;6.5*<sup>&#x02206;</sup></td></tr></tbody></table><table-wrap-foot><p>*p&#x0003c;0.05 compared with the value at baseline, by the Wilcoxon&#x02019;s test.
<sup>&#x02206;</sup>p&#x0003c;0.05 compared with the value in control group, by the Mann-Whitney U
test. BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; Scr, serum
creatinine</p></table-wrap-foot></table-wrap>, 12 weeks of regular Tai Chi intervention significantly improved eGFR in the
exercise group, but we did not find a change in the control group. There were significant
differences in the changes of eGFR and Scr between the two groups. Although, the exercise
had no significant effect on BUN in either group, the change of BUN in the exercise group
showed a slight decline trend compared to the control group.</p><p>Compared with baseline, 12 weeks of Tai Chi exercise decreased CH, TG and LDL levels and
increased the HDL levels (<xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Comparison of lipid parameters between baseline and 12 weeks</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="left" colspan="1"/><th colspan="2" align="center" rowspan="1">Control group</th><th colspan="2" align="center" rowspan="1">Exercise group</th></tr><tr><th colspan="2" align="center" rowspan="1"><hr/></th><th colspan="2" align="center" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">12 weeks</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">12 weeks</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CH (mmol/L)</td><td align="center" rowspan="1" colspan="1">5.63&#x000b1;0.77</td><td align="center" rowspan="1" colspan="1">5.70&#x000b1;0.83</td><td align="center" rowspan="1" colspan="1">5.60&#x000b1;0.81</td><td align="center" rowspan="1" colspan="1">5.03&#x000b1;0.92*<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mmol/L)</td><td align="center" rowspan="1" colspan="1">1.51&#x000b1;0.78</td><td align="center" rowspan="1" colspan="1">1.54&#x000b1;0.68</td><td align="center" rowspan="1" colspan="1">1.56&#x000b1;0.73</td><td align="center" rowspan="1" colspan="1">1.41&#x000b1;0.55*<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">LDL (mmol/L)</td><td align="center" rowspan="1" colspan="1">3.73&#x000b1;0.82</td><td align="center" rowspan="1" colspan="1">3.78&#x000b1;0.56</td><td align="center" rowspan="1" colspan="1">3.67&#x000b1;0.89</td><td align="center" rowspan="1" colspan="1">3.36&#x000b1;0.44*<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">HDL (mmol/L)</td><td align="center" rowspan="1" colspan="1">1.15&#x000b1;0.51</td><td align="center" rowspan="1" colspan="1">1.11&#x000b1;0.60</td><td align="center" rowspan="1" colspan="1">1.08&#x000b1;0.56</td><td align="center" rowspan="1" colspan="1">1.18&#x000b1;0.37*<sup>&#x02206;</sup></td></tr></tbody></table><table-wrap-foot><p>*p&#x0003c;0.05 compared with the value at baseline, by the Wilcoxon&#x02019;s test.
<sup>&#x02206;</sup>p&#x0003c;0.05 compared with the value in control group, by the Mann-Whitney U
test. CH, total cholesterol; HDL, high density lipoprotein; LDL, low density
lipoprotein; TG, triglyceride</p></table-wrap-foot></table-wrap>); no differences were seen in control group. The changes in blood lipid
parameters were markedly different between the control and the exercise groups.</p><p><xref rid="tbl_004" ref-type="table">Table 4</xref><table-wrap id="tbl_004" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Comparison of cardiac function between baseline and 12 weeks</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="left" colspan="1"/><th colspan="2" align="center" rowspan="1">Control group</th><th colspan="2" align="center" rowspan="1">Exercise group</th></tr><tr><th colspan="2" align="center" rowspan="1"><hr/></th><th colspan="2" align="center" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">12 weeks</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">12 weeks</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SBP (mmHg)</td><td align="center" rowspan="1" colspan="1">145&#x000b1;21</td><td align="center" rowspan="1" colspan="1">149&#x000b1;19</td><td align="center" rowspan="1" colspan="1">142&#x000b1;18</td><td align="center" rowspan="1" colspan="1">129&#x000b1;16*<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mmHg)</td><td align="center" rowspan="1" colspan="1">89&#x000b1;12</td><td align="center" rowspan="1" colspan="1">92&#x000b1;11</td><td align="center" rowspan="1" colspan="1">88&#x000b1;13</td><td align="center" rowspan="1" colspan="1">80&#x000b1;10*<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">HR (bpm)</td><td align="center" rowspan="1" colspan="1">72&#x000b1;11</td><td align="center" rowspan="1" colspan="1">73&#x000b1;12</td><td align="center" rowspan="1" colspan="1">74&#x000b1;10</td><td align="center" rowspan="1" colspan="1">65&#x000b1;8*<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF (%)</td><td align="center" rowspan="1" colspan="1">56.3&#x000b1;13.9</td><td align="center" rowspan="1" colspan="1">57.1&#x000b1;12.2</td><td align="center" rowspan="1" colspan="1">56.5&#x000b1;12.3</td><td align="center" rowspan="1" colspan="1">63.5&#x000b1;10.7*<sup>&#x02206;</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">LVDD (mm)</td><td align="center" rowspan="1" colspan="1">44.0&#x000b1;6.0</td><td align="center" rowspan="1" colspan="1">43.9&#x000b1;6.9</td><td align="center" rowspan="1" colspan="1">44.2&#x000b1;6.6</td><td align="center" rowspan="1" colspan="1">43.8&#x000b1;4.7</td></tr><tr><td align="left" rowspan="1" colspan="1">LVSD (mm)</td><td align="center" rowspan="1" colspan="1">31.9&#x000b1;5.7</td><td align="center" rowspan="1" colspan="1">32.5&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">32.4&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">31.2&#x000b1;3.8</td></tr></tbody></table><table-wrap-foot><p>*p&#x0003c;0.05 compared with the value at baseline, by the Wilcoxon&#x02019;s test.
<sup>&#x02206;</sup>p&#x0003c;0.05 compared with the value in control group, by the Mann-Whitney U
test. DBP, diastolic blood pressure; HR, heart rate; LVDD, left ventricular diastolic
diameter; LVEF, left ventricular ejection fraction; LVSD, left ventricular systolic
diameter; SBP, systolic blood pressure</p></table-wrap-foot></table-wrap> shows that SBP, DBP and HR reduced notably after 12 weeks of Tai Chi exercise;
there was no variations were observed in the control group. The SBP, DBP and HR in the
exercise group after 12 weeks of Tai Chi intervention were clearly lower than the values of
the control group which did not perform Tai Chi exercise.</p><p>After 12 weeks of Tai Chi exercise, LVEF in the exercise group had increased by an average
of 10% compared to baseline in spite of there being no change in LVDD and LVSD (<xref rid="tbl_004" ref-type="table">Table 4</xref>). Moreover, HR in the exercise group
decreased, but we failed to find a significant change in the control group. The changes in
HR and LVEF in the exercise group after 12 weeks of Tai Chi intervention had showed
significant differences from those of in the control group.</p><p>In the exercise group, the change in eGFR negatively correlated with the changes in CH, TG
and LDL, and positively with the change in HDL (<xref rid="tbl_005" ref-type="table">Table
5</xref><table-wrap id="tbl_005" orientation="portrait" position="float"><label>Table 5.</label><caption><title>Correlation of exercise group changes in eGFR, SBP and lipid parameters</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="left" colspan="1"/><th colspan="2" align="center" rowspan="1">eGFR</th><th colspan="2" align="center" rowspan="1">SBP</th></tr><tr><th colspan="2" align="center" rowspan="1"><hr/></th><th colspan="2" align="center" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">p</th><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CH (mmol/L)</td><td align="center" rowspan="1" colspan="1">&#x02212;0.462</td><td align="center" rowspan="1" colspan="1">0.036</td><td align="center" rowspan="1" colspan="1">0.487</td><td align="center" rowspan="1" colspan="1">0.035</td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mmol/L)</td><td align="center" rowspan="1" colspan="1">&#x02212;0.512</td><td align="center" rowspan="1" colspan="1">0.025</td><td align="center" rowspan="1" colspan="1">0.545</td><td align="center" rowspan="1" colspan="1">0.012</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL (mmol/L)</td><td align="center" rowspan="1" colspan="1">&#x02212;0.536</td><td align="center" rowspan="1" colspan="1">0.018</td><td align="center" rowspan="1" colspan="1">0.529</td><td align="center" rowspan="1" colspan="1">0.021</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL (mmol/L)</td><td align="center" rowspan="1" colspan="1">0.675</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">&#x02212;0.633</td><td align="center" rowspan="1" colspan="1">0.002</td></tr></tbody></table><table-wrap-foot><p>CH, total cholesterol; eGFR, estimated glomerular filtration rate; HDL, high density
lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; TG,
triglyceride</p></table-wrap-foot></table-wrap>). Also, the change in SBP correlated positively with the changes in CH, TG and
LDL, and negatively with the change in HDL.</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>We evaluated the effects of Tai Chi training on the renal, and cardiac functions and blood
lipid parameters of patients with CKD and CVD. The 12 weeks of Tai Chi training resulted in
significant changes in eGFR, CH, TG, LDL, HDL, HR, SBP, DBP, and LVEF in the exercise group
while no changes were observed in the control group. To the best of our knowledge, this is
the first clinical study to showing the potential benefits of Tai Chi training in CKD and
CVD patients.</p><p>The presence of high TG and low HDL, as is well documented in previous reports, accelerates
the progression of CKD<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref><sup>)</sup>. Aerobic
exercise usually decreases TG and increases HDL in patients with CVD<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r19" ref-type="bibr">19</xref><sup>)</sup>. Moreover,
several studies have indicated that the elevation of the HDL level could improve renal
function<xref rid="r20" ref-type="bibr">20</xref>, <xref rid="r21" ref-type="bibr">21</xref><sup>)</sup>. Our results are consistent with these previous reports, which
suggest that regular Tai Chi training can improve the renal and cardiac functions through
promotion of blood lipid metabolism, and especially HDL elevation. Consequently, Tai Chi
appears to be an effective exercise for preventing the progression of CKD and CVD.</p><p>In spite of abundant evidence of the benefits of exercise for CKD and CVD patients<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref><sup>)</sup>,
and the fact that exercise was first reported to improved abnormal metabolism in patients
with CKD was first introduced 3 decades ago<xref rid="r22" ref-type="bibr">22</xref><sup>)</sup>, therapeutic exercise for advanced CKD patients is still not
widespread. What are the causes of the current situation? One possibility is that there is
no specific exercise guideline for this group of patients yet. Another reason may be that
the majority CKD and CVD patients fail to keep walking, jogging, swimming, cycling or
climbing, because their condition makes them susceptible to fatigue rendering them to
persist with such exercises. A third possibility is that some exercises require equipment
which is unavailable for outpatients. Therefore, it is necessary to find a simple, easy,
suitably available and effective way of exercise for patients with CKD and CVD. In view of
the above requirements, Tai Chi is undoubtedly the best choice. Ours and others studies have
demonstrated the broad benefits of Tai Chi for CKD and CVD patients<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref><sup>)</sup>.</p><p>Our study had several limitations. First, the present study was a small sample size pilot
study, which only included 21 patients, and our results need to be confirmed in further
larger trails. Second, the intervention period was only 12 weeks, and it is necessary to
examine the long-term effects of Tai Chi training. Third, the lack of blinding with patients
may have influenced our results. Furthermore, our study didn&#x02019;t take gender, social status or
severity of the disease into account. In addition, further studies are also needed to
explore the combination effect of Tai Chi with resistance exercise on CKD and CVD. However,
since the aim of our study was to confirm the beneficial effects of Tai Chi training on the
renal and cardiac functions of patients with CKD and CVD, and we believe it is a valuable
study in that it has provided results which warrant.</p><p>Our results confirmed Tai Chi training might improve the renal and cardiac functions of
patients with CKD and CVD through modification of blood lipid metabolism. Although further
investigations are needed to uncover the mechanisms behind the improvements, Tai Chi may be
an easy and effective clinical treatment strategy for preventing the progression of CKD and
CVD, enhancing live quality of life, and increasing life span.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Blaine</surname><given-names>J</given-names></name><name><surname>Levi</surname><given-names>M</given-names></name></person-group>: <article-title>Chronic kidney disease: albuminuria or CKD stage as best
marker of CVD in diabetes</article-title>? <source>Nat Rev Nephrol</source>,
<year>2012</year>, <volume>8</volume>: <fpage>376</fpage>&#x02013;<lpage>377</lpage>.
<pub-id pub-id-type="pmid">22641078</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Schiffrin</surname><given-names>EL</given-names></name><name><surname>Lipman</surname><given-names>ML</given-names></name><name><surname>Mann</surname><given-names>JF</given-names></name></person-group>: <article-title>Chronic kidney disease: effects on the cardiovascular
system</article-title>. <source>Circulation</source>, <year>2007</year>,
<volume>116</volume>: <fpage>85</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="pmid">17606856</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Shlipak</surname><given-names>MG</given-names></name><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>Cardiovascular mortality risk in chronic kidney disease:
comparison of traditional and novel risk factors</article-title>. <source>JAMA</source>,
<year>2005</year>, <volume>293</volume>: <fpage>1737</fpage>&#x02013;<lpage>1745</lpage>.
<pub-id pub-id-type="pmid">15827312</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Sietsema</surname><given-names>KE</given-names></name><name><surname>Amato</surname><given-names>A</given-names></name><name><surname>Adler</surname><given-names>SG</given-names></name><etal>et al.</etal></person-group>: <article-title>Exercise capacity as a predictor of survival among
ambulatory patients with end-stage renal disease</article-title>. <source>Kidney
Int</source>, <year>2004</year>, <volume>65</volume>:
<fpage>719</fpage>&#x02013;<lpage>724</lpage>. <pub-id pub-id-type="pmid">14717947</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Stack</surname><given-names>AG</given-names></name><name><surname>Molony</surname><given-names>DA</given-names></name><name><surname>Rives</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>: <article-title>Association of physical activity with mortality in the US
dialysis population</article-title>. <source>Am J Kidney Dis</source>,
<year>2005</year>, <volume>45</volume>: <fpage>690</fpage>&#x02013;<lpage>701</lpage>.
<pub-id pub-id-type="pmid">15806472</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Henrique</surname><given-names>DM</given-names></name><name><surname>Reboredo</surname><given-names>MM</given-names></name><name><surname>Chaoubah</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>[Aerobic exercise improves physical capacity in patients
under chronic hemodialysis]</article-title>. <source>Arq Bras Cardiol</source>,
<year>2010</year>, <volume>94</volume>: <fpage>823</fpage>&#x02013;<lpage>828</lpage>.
<pub-id pub-id-type="pmid">20428710</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Kohzuki</surname><given-names>M</given-names></name><name><surname>Kamimoto</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>XM</given-names></name><etal>et al.</etal></person-group>: <article-title>Renal protective effects of chronic exercise and
antihypertensive therapy in hypertensive rats with chronic renal
failure</article-title>. <source>J Hypertens</source>, <year>2001</year>,
<volume>19</volume>: <fpage>1877</fpage>&#x02013;<lpage>1882</lpage>. <pub-id pub-id-type="pmid">11593110</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Kosmadakis</surname><given-names>GC</given-names></name><name><surname>John</surname><given-names>SG</given-names></name><name><surname>Clapp</surname><given-names>EL</given-names></name><etal>et al.</etal></person-group>: <article-title>Benefits of regular walking exercise in advanced
pre-dialysis chronic kidney disease</article-title>. <source>Nephrol Dial
Transplant</source>, <year>2012</year>, <volume>27</volume>:
<fpage>997</fpage>&#x02013;<lpage>1004</lpage>. <pub-id pub-id-type="pmid">21795756</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="book">Nationl Collaborating Centre for
Chronic Conditions: Chronic Kidney Disease: National Clinical Guideline for Early
Identification and Management in Adults in Primary and Secondary Care. London: Royal
College of Physicians, <year>2008</year>.</mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Johansen</surname><given-names>KL</given-names></name></person-group>: <article-title>Exercise and dialysis</article-title>. <source>Hemodial
Int</source>, <year>2008</year>, <volume>12</volume>:
<fpage>290</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="pmid">18638081</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name></person-group>: <article-title>The effect of Tai Chi on health outcomes in patients with
chronic conditions: a systematic review</article-title>. <source>Arch Intern
Med</source>, <year>2004</year>, <volume>164</volume>:
<fpage>493</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="pmid">15006825</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Taylor-Piliae</surname><given-names>RE</given-names></name><name><surname>Silva</surname><given-names>E</given-names></name><name><surname>Sheremeta</surname><given-names>SP</given-names></name></person-group>: <article-title>Tai Chi as an adjunct physical activity for adults aged 45
years and older enrolled in phase III cardiac rehabilitation</article-title>.
<source>Eur J Cardiovasc Nurs</source>, <year>2012</year>, <volume>11</volume>:
<fpage>34</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="pmid">21095159</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>HD</given-names></name><name><surname>Kim</surname><given-names>TY</given-names></name><name><surname>Jae</surname><given-names>HD</given-names></name><etal>et al.</etal></person-group>: <article-title>The effects of tai chi based exercise on dynamic postural
control of parkinson&#x02019;s disease patients while initiating gait</article-title>. <source>J
Phys Ther Sci</source>, <year>2011</year>, <volume>23</volume>:
<fpage>265</fpage>&#x02013;<lpage>269</lpage>. </mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Ko</surname><given-names>GT</given-names></name><name><surname>So</surname><given-names>WY</given-names></name><etal>et al.</etal></person-group>: <article-title>Associations of hyperglycemia and insulin usage with the
risk of cancer in type 2 diabetes: the Hong Kong diabetes registry</article-title>.
<source>Diabetes</source>, <year>2010</year>, <volume>59</volume>:
<fpage>1254</fpage>&#x02013;<lpage>1260</lpage>. <pub-id pub-id-type="pmid">20185812</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Harper</surname><given-names>CR</given-names></name><name><surname>Jacobson</surname><given-names>TA</given-names></name></person-group>: <article-title>Managing dyslipidemia in chronic kidney
disease</article-title>. <source>J Am Coll Cardiol</source>, <year>2008</year>,
<volume>51</volume>: <fpage>2375</fpage>&#x02013;<lpage>2384</lpage>. <pub-id pub-id-type="pmid">18565393</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Tsimihodimos</surname><given-names>V</given-names></name><name><surname>Mitrogianni</surname><given-names>Z</given-names></name><name><surname>Elisaf</surname><given-names>M</given-names></name></person-group>: <article-title>Dyslipidemia associated with chronic kidney
disease</article-title>. <source>Open Cardiovasc Med J</source>, <year>2011</year>,
<volume>5</volume>: <fpage>41</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="pmid">21643500</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Chen</surname><given-names>SC</given-names></name><name><surname>Hung</surname><given-names>CC</given-names></name><name><surname>Kuo</surname><given-names>MC</given-names></name><etal>et al.</etal></person-group>: <article-title>Association of dyslipidemia with renal outcomes in chronic
kidney disease</article-title>. <source>PLoS ONE</source>, <year>2013</year>,
<volume>8</volume>: <fpage>e55643</fpage>. <pub-id pub-id-type="pmid">23390545</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Herzberg</surname><given-names>GR</given-names></name></person-group>: <article-title>Aerobic exercise, lipoproteins, and cardiovascular
disease: benefits and possible risks</article-title>. <source>Can J Appl
Physiol</source>, <year>2004</year>, <volume>29</volume>:
<fpage>800</fpage>&#x02013;<lpage>807</lpage>. <pub-id pub-id-type="pmid">15630151</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Kelley</surname><given-names>GA</given-names></name><name><surname>Kelley</surname><given-names>KS</given-names></name><name><surname>Franklin</surname><given-names>B</given-names></name></person-group>: <article-title>Aerobic exercise and lipids and lipoproteins in patients
with cardiovascular disease: a meta-analysis of randomized controlled
trials</article-title>. <source>J Cardiopulm Rehabil</source>, <year>2006</year>,
<volume>26</volume>: <fpage>131</fpage>&#x02013;<lpage>139, quiz 140&#x02013;141, discussion
142&#x02013;144</lpage>. <pub-id pub-id-type="pmid">16738448</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Toyama</surname><given-names>K</given-names></name><name><surname>Sugiyama</surname><given-names>S</given-names></name><name><surname>Oka</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>Exercise therapy correlates with improving renal function
through modifying lipid metabolism in patients with cardiovascular disease and chronic
kidney disease</article-title>. <source>J Cardiol</source>, <year>2010</year>,
<volume>56</volume>: <fpage>142</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="pmid">20696551</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Athyros</surname><given-names>VG</given-names></name><name><surname>Kakafika</surname><given-names>AI</given-names></name><name><surname>Papageorgiou</surname><given-names>AA</given-names></name><etal>et al.</etal></person-group>: <article-title>Statin-induced increase in HDL-C and renal function in
coronary heart disease patients</article-title>. <source>Open Cardiovasc Med J</source>,
<year>2007</year>, <volume>1</volume>: <fpage>8</fpage>&#x02013;<lpage>14</lpage>.
<pub-id pub-id-type="pmid">18949085</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Goldberg</surname><given-names>AP</given-names></name><name><surname>Hagberg</surname><given-names>JM</given-names></name><name><surname>Delmez</surname><given-names>JA</given-names></name><etal>et al.</etal></person-group>: <article-title>Exercise training improves abnormal lipid and carbohydrate
metabolism in hemodialysis patients</article-title>. <source>Trans Am Soc Artif Intern
Organs</source>, <year>1979</year>, <volume>25</volume>:
<fpage>431</fpage>&#x02013;<lpage>437</lpage>. <pub-id pub-id-type="pmid">230627</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Park</surname><given-names>IS</given-names></name><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Oh</surname><given-names>KO</given-names></name><etal>et al.</etal></person-group>: <article-title>Managing cardiovascular risks with Tai Chi in people with
coronary artery disease</article-title>. <source>J Adv Nurs</source>, <year>2010</year>,
<volume>66</volume>: <fpage>282</fpage>&#x02013;<lpage>292</lpage>. <pub-id pub-id-type="pmid">20423411</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Pittler</surname><given-names>MH</given-names></name><name><surname>Taylor-Piliae</surname><given-names>RE</given-names></name><etal>et al.</etal></person-group>: <article-title>Tai chi for cardiovascular disease and its risk factors: a
systematic review</article-title>. <source>J Hypertens</source>, <year>2007</year>,
<volume>25</volume>: <fpage>1974</fpage>&#x02013;<lpage>1975</lpage>. <pub-id pub-id-type="pmid">17762664</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Taylor-Piliae</surname><given-names>RE</given-names></name><name><surname>Haskell</surname><given-names>WL</given-names></name><name><surname>Stotts</surname><given-names>NA</given-names></name><etal>et al.</etal></person-group>: <article-title>Improvement in balance, strength, and flexibility after 12
weeks of Tai chi exercise in ethnic Chinese adults with cardiovascular disease risk
factors</article-title>. <source>Altern Ther Health Med</source>, <year>2006</year>,
<volume>12</volume>: <fpage>50</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="pmid">16541997</pub-id></mixed-citation></ref></ref-list></back></article>
